We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
9lnj
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 9lnj is ON HOLD Authors: Description: Category: Unreleased Structures) |
|||
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Crystal structure of VANC21 in complex with its target DNA (5-bromouridine substituted).== | |
| + | <StructureSection load='9lnj' size='340' side='right'caption='[[9lnj]], [[Resolution|resolution]] 2.00Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[9lnj]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Arabidopsis_thaliana Arabidopsis thaliana]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=9LNJ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=9LNJ FirstGlance]. <br> | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2Å</td></tr> | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=3D1:(2R,3S,5R)-5-(6-AMINO-9H-PURIN-9-YL)-TETRAHYDRO-2-(HYDROXYMETHYL)FURAN-3-OL'>3D1</scene>, <scene name='pdbligand=BRU:5-BROMO-2-DEOXYURIDINE-5-MONOPHOSPHATE'>BRU</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=9lnj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=9lnj OCA], [https://pdbe.org/9lnj PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=9lnj RCSB], [https://www.ebi.ac.uk/pdbsum/9lnj PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=9lnj ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/O80464_ARATH O80464_ARATH] | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | VANDAL family transposons are DNA transposons prevalent in Arabidopsis and related plants. A notable feature of VANDAL is that they can overcome epigenetic silencing from the host, using a VANC protein encoded in each VANDAL members: VANC21 protein encoded in VANDAL21 specifically accumulates on its target DNA motifs condensed in the non-coding regions of this TE and induces loss of DNA methylation, transcriptional derepression, and mobilization of them. In this study, to elucidate the mechanism of how VANC subtypes have diverged to bind specifically to their own target motifs in their cognate VANDAL subfamilies, we determined the crystal structure of VANC21 in complex with its target DNA at 2.0 A resolution. The VANC structure adopts a globular novel fold with a Zn ion coordinated at the DNA-binding site. Interestingly, most DNA-interacting VANC residues are located in the loops but not in the conserved regions among VANC subtypes. This observation suggests that the high variability of DNA-interacting regions of VANC proteins brought about the co-evolution of VANCs and their target sequences. This rapid differentiation by co-evolution enabled VANDAL family TEs to proliferate while avoiding deleterious effects on the host fitness. Therefore, our findings help understand the adaptive evolutionary strategy for the survival of parasitic sequences. | ||
| - | + | Structure and evolution of the sequence-specific anti-silencing factor VANC21 and its target DNA.,Tanaka Y, Osakabe A, Shihoya W, Hirano H, Itoh Y, Kakutani T, Nureki O Genes Genet Syst. 2025 Nov 19. doi: 10.1266/ggs.25-00096. PMID:41260640<ref>PMID:41260640</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | [[Category: | + | </div> |
| + | <div class="pdbe-citations 9lnj" style="background-color:#fffaf0;"></div> | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Arabidopsis thaliana]] | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Hirano H]] | ||
| + | [[Category: Itoh Y]] | ||
| + | [[Category: Kakutani T]] | ||
| + | [[Category: Nureki O]] | ||
| + | [[Category: Shihoya W]] | ||
| + | [[Category: Tanaka Y]] | ||
Current revision
Crystal structure of VANC21 in complex with its target DNA (5-bromouridine substituted).
| |||||||||||
